News

The trial of IMAB027, which is a first-in-class monoclonal antibody targeting the tight junction protein Claudin-6 (CLDN6), is being carried out in Germany, Belgium, Russia and Ukraine. Ganymed

The clinical assets include AFN-1252, a FabI inhibitor designated by the FDA as a Qualified Infectious Disease Product (QIDP) which has successfully completed a Phase 2a study for

"We are pleased to offer patients with treatment-resistant schizophrenia a new liquid formulation of clozapine that is FDA approved to treat this difficult condition," said Bruce C. Cozadd,

The company said that Phase III clinical trials in type 1 and type 2 diabetes will commence soon. Merck senior vice president of Diabetes, Global Human Health Matt

The company already has exclusive rights of Cynviloq from Samyang in the US and the 27 countries of the European Union (EU). Sorrento president and chief executive officer

Under the deal, SynCo will manufacture Advaxis’ novel drug candidate, ADXS-HPV as well as assist them in developing scale-up and commercial manufacturing processes for ADXS-HPV bulk drug substance

As part of this multi-faceted partnership with The V Foundation, Medifast will fund research grants that explore the link between obesity and cancer and the impact of healthy

The company said that ENU is a naturally improved, complete nutritional shake that is flavorful, with 25g of protein per serving and 40% less sugar per ounce compared

The marketing effort will be conducted via the Help Now Network (HNN), a healthcare marketing company and its affiliates. SugarDown is a dietary supplement that is indicated in